XML 34 R24.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Summary of Shares Available for Issuance Under 2020 Plan

A summary of the shares available for issuance under the 2020 Plan is as follows:

 

 

Number of Shares

 

Balance at December 31, 2021

 

 

1,082

 

Authorized

 

 

549

 

Granted/Awarded

 

 

(536

)

Cancelled

 

 

32

 

Balance at March 31, 2022

 

 

1,127

 

Summary of Option Award Activity

Option award activity under the 2020 Plan is set forth below:

 

 

Options Outstanding

 

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term (In Years)

 

 

Aggregate Intrinsic Value

 

Outstanding at December 31, 2021

 

 

653

 

 

$

7.57

 

 

 

9.3

 

 

$

 

Options granted

 

 

476

 

 

$

6.04

 

 

 

 

 

 

 

 

 

Options exercised

 

 

 

 

$

 

 

 

 

 

 

 

 

 

Options cancelled

 

 

(27

)

 

$

6.88

 

 

 

 

 

 

 

 

 

Outstanding at March 31, 2022

 

 

1,102

 

 

$

6.92

 

 

 

9.3

 

 

$

752

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at March 31, 2022

 

 

1,102

 

 

$

6.92

 

 

 

9.3

 

 

$

752

 

Vested and exercisable at March 31, 2022

 

 

203

 

 

$

7.71

 

 

 

9.0

 

 

$

11

 

Summary of Fair Value of Stock Options was Estimated Using Assumptions

The Company estimated the fair value of stock-options using the Black-Scholes option pricing model. The fair value of stock options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of stock options was estimated using the following assumptions for the three months ended March 31, 2022 and 2021:

 

 

Three Months Ended

March 31,

 

 

2022

 

2021

Risk-free interest rate

 

1.5 - 1.6%

 

0.6 - 1.1%

Expected term (years)

 

6

 

6

Expected volatility

 

70%

 

72 - 73%

Dividends

 

0.0%

 

0.0%

Summary of Total Stock-Based Compensation Expense Recognized

The following table sets forth the total stock-based compensation expense recognized under the 2020 Plan and the 2020 ESPP in the Company’s condensed statements of operations:

 

 

Three Months Ended

March 31,

 

 

 

2022

 

 

2021

 

Cost of revenue – product

 

$

52

 

 

$

75

 

Cost of revenue – service

 

 

30

 

 

 

41

 

Selling, general and administrative expenses

 

 

1,377

 

 

 

1,984

 

Research and development expenses

 

 

148

 

 

 

220

 

Total

 

$

1,607

 

 

$

2,320

 

Summary of Unrecognized Stock-based Compensation Expense Expected to be Amortized

Total unrecognized stock-based compensation expense is expected to be amortized as follows:

Fiscal Year

 

Amount

 

2022

 

 

4,498

 

2023

 

 

3,988

 

2024

 

 

984

 

2025

 

 

625

 

2026

 

 

13

 

Thereafter

 

 

 

Total unrecognized stock-based compensation expense

 

$

10,108

 

Restricted Stock Awards  
Summary of Restricted Stock Award and Restricted Stock Units Activity

Restricted stock award activity under the 2020 Plan is set forth below:

 

 

Restricted Stock Awards Outstanding

 

 

 

Number of Units

 

 

Weighted Average Grant Date Fair Value Per Share

 

Non-vested at December 31, 2021

 

 

1,332

 

 

$

10.29

 

Restricted stock awards granted

 

 

 

 

$

 

Restricted stock awards vested

 

 

(338

)

 

$

10.38

 

Restricted stock awards cancelled

 

 

(5

)

 

$

10.81

 

Non-vested at March 31, 2022

 

 

989

 

 

$

10.26

 

Restricted Stock Units  
Summary of Restricted Stock Award and Restricted Stock Units Activity

Restricted stock units granted to employees generally vest over four years in annual equal increments. The fair value of restricted stock units is based on the Company’s closing stock price on the date of grant.


 

Restricted stock unit activity under the 2020 Plan is set forth below:

 

 

Restricted Stock Units Outstanding

 

 

 

Number of Units

 

 

Weighted Average Grant Date Fair Value Per Share

 

Non-vested at December 31, 2021

 

 

 

 

$

 

Restricted stock units granted

 

 

60

 

 

$

6.04

 

Restricted stock units vested

 

 

 

 

$

 

Restricted stock units cancelled

 

 

 

 

$

 

Non-vested at March 31, 2022

 

 

60

 

 

$

6.04